Delivery Order SPE2DB22D2206-SPE2DB25FFF06
Award Date
1/23/25
Potential Completion Date
2/13/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The firm-fixed-price contract has a ceiling value of $16,032.60 and an ultimate completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,504.62 firm-fixed-price contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML medical products. The contract has a ceiling value of $7,857.74 and a performance period running through January 18, 2024. The contract is a firm fixed-price delivery order, and does not have a set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,504.62 firm fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,293.34 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 29, 2024, with a completion date of December 20, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,016.30, is for the delivery of 840 mg/14 mL vials of the drug Tecentriq. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a delivery order (SPE2DB20D1100|SPE2DB24FA7E7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product, at a firm fixed price of $16,032.60. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,504.62 firm fixed-price delivery order is for the supply of 840 mg/14 ml vials of the drug Tecentriq. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 3, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $16,032.60 Firm Fixed Price Delivery Order contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $7,857.74 firm fixed price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The contract has a completion date of January 23, 2024 and was awarded on December 29, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp is a prime...